At INCATE, we are committed to providing support to early-stage innovators working on antimicrobial resistance (AMR). As the landscape of innovation and funding continues to evolve, so must we. Recognizing the increasing importance of strategic [...]
More news
Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways [...]
November 1st, 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) and BIOASTER, the [...]
The Entrepreneurs Club is back! Join this 3rd INCATE Entrepreneurs Club on "Creative Funding - [...]
Nijmegen, 12th September 2023 - By the occasion of the World Sepsis Day, SurvivX is [...]
The next INCATE's Selection Committee is coming up and we are now accepting applications for [...]
2023 has reached its final quarter and there are still quite a number of events [...]
6th September 2023 - INCATE (the INCubator for Antibacterial Therapies in Europe) has successfully reached [...]
INCATE PRESS RELEASE 08, May 2023 For immediate release INCATE has selected Invitris as the [...]
